KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cognex (CGNX) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Cognex (CGNX) over the last 17 years, with Sep 2025 value amounting to $169.5 million.

  • Cognex's Shares Outstanding (Diluted Average) fell 1.88% to $169.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.5 million, marking a year-over-year decrease of 1.88%. This contributed to the annual value of $172.6 million for FY2024, which is 0.45% down from last year.
  • Cognex's Shares Outstanding (Diluted Average) amounted to $169.5 million in Q3 2025, which was down 0.03% from $169.6 million recorded in Q2 2025.
  • Cognex's 5-year Shares Outstanding (Diluted Average) high stood at $180.3 million for Q4 2021, and its period low was $169.5 million during Q3 2025.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $172.7 million (2024), whereas its average is $172.3 million.
  • In the last 5 years, Cognex's Shares Outstanding (Diluted Average) rose by 2.56% in 2021 and then decreased by 2.83% in 2022.
  • Cognex's Shares Outstanding (Diluted Average) (Quarterly) stood at $179.9 million in 2021, then fell by 2.81% to $174.9 million in 2022, then decreased by 0.84% to $173.4 million in 2023, then fell by 0.45% to $172.6 million in 2024, then fell by 1.88% to $169.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $169.5 million in Q3 2025, compared to $169.6 million in Q2 2025 and $170.4 million in Q1 2025.